Cargando…

Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity

Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyrvig, Anne-Kirstine, Yderstræde, Knud Bonnet, Gerke, Oke, Jensen, Peter Bjødstrup, Hess, Søren, Høilund-Carlsen, Poul Flemming, Green, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406101/
https://www.ncbi.nlm.nih.gov/pubmed/28422885
http://dx.doi.org/10.1097/MD.0000000000006693
_version_ 1783231905350549504
author Dyrvig, Anne-Kirstine
Yderstræde, Knud Bonnet
Gerke, Oke
Jensen, Peter Bjødstrup
Hess, Søren
Høilund-Carlsen, Poul Flemming
Green, Anders
author_facet Dyrvig, Anne-Kirstine
Yderstræde, Knud Bonnet
Gerke, Oke
Jensen, Peter Bjødstrup
Hess, Søren
Høilund-Carlsen, Poul Flemming
Green, Anders
author_sort Dyrvig, Anne-Kirstine
collection PubMed
description Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We compared procedures performed in suspected CUP patients with recommendations of national guidelines to assess external validity of guidelines. The Danish National Patient Registry (NPR) comprising population data was utilized to identify the suspected CUP patients during 2009 to 2010 and explore exposure to procedures and patient survival. The cohort was investigated in terms of validity of diagnosis through cross-referencing with the Cancer Registry (CR), which served as gold standard for cancer diagnoses and patients’ cancer histories. The NPR cohort consisted of 542 patients (275 males, 264 females) of whom 210 (38.7%) had a CUP diagnosis confirmed. Within the cohort, 347 patients (64.0%) had a registration in CR matching with the NPR registration. Exposure to diagnostic procedures included biopsy (n = 439, 81.0%) and image modalities (n = 532, 98.2%). Survival was poor with 67 (12.4%) individuals alive after 4 years. The validity of a CUP diagnosis in NPR was low when using data from CR as reference. More than half the suspected CUP patients had a previous cancer diagnosis with CUP being the most frequent. Patients were diagnosed in compliance with guidelines indicating high external validity, but less than 1 quarter had their primary identified and the 1-year survival was approximately 20%. Research is needed to develop efficacious methods for primary detection.
format Online
Article
Text
id pubmed-5406101
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-54061012017-04-28 Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity Dyrvig, Anne-Kirstine Yderstræde, Knud Bonnet Gerke, Oke Jensen, Peter Bjødstrup Hess, Søren Høilund-Carlsen, Poul Flemming Green, Anders Medicine (Baltimore) 4400 Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We compared procedures performed in suspected CUP patients with recommendations of national guidelines to assess external validity of guidelines. The Danish National Patient Registry (NPR) comprising population data was utilized to identify the suspected CUP patients during 2009 to 2010 and explore exposure to procedures and patient survival. The cohort was investigated in terms of validity of diagnosis through cross-referencing with the Cancer Registry (CR), which served as gold standard for cancer diagnoses and patients’ cancer histories. The NPR cohort consisted of 542 patients (275 males, 264 females) of whom 210 (38.7%) had a CUP diagnosis confirmed. Within the cohort, 347 patients (64.0%) had a registration in CR matching with the NPR registration. Exposure to diagnostic procedures included biopsy (n = 439, 81.0%) and image modalities (n = 532, 98.2%). Survival was poor with 67 (12.4%) individuals alive after 4 years. The validity of a CUP diagnosis in NPR was low when using data from CR as reference. More than half the suspected CUP patients had a previous cancer diagnosis with CUP being the most frequent. Patients were diagnosed in compliance with guidelines indicating high external validity, but less than 1 quarter had their primary identified and the 1-year survival was approximately 20%. Research is needed to develop efficacious methods for primary detection. Wolters Kluwer Health 2017-04-21 /pmc/articles/PMC5406101/ /pubmed/28422885 http://dx.doi.org/10.1097/MD.0000000000006693 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4400
Dyrvig, Anne-Kirstine
Yderstræde, Knud Bonnet
Gerke, Oke
Jensen, Peter Bjødstrup
Hess, Søren
Høilund-Carlsen, Poul Flemming
Green, Anders
Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title_full Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title_fullStr Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title_full_unstemmed Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title_short Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
title_sort cancer of unknown primary: registered procedures compared with national integrated cancer pathway for illuminating external validity
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406101/
https://www.ncbi.nlm.nih.gov/pubmed/28422885
http://dx.doi.org/10.1097/MD.0000000000006693
work_keys_str_mv AT dyrvigannekirstine cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT yderstrædeknudbonnet cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT gerkeoke cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT jensenpeterbjødstrup cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT hesssøren cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT høilundcarlsenpoulflemming cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity
AT greenanders cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity